The spectrum of extrahepatic manifestations in hepatitis C virus infection

Journal of Viral Hepatitis

Volumn 4, Issue 1, 1997, Pages 9-28

  Hadziyannis, S J ^a  

^a HIPPOKRATION HOSPITAL   (Greece)

Author keywords

Autoimmune disorders; Extrahepatic manifestations; Hepatitis C; Interferon

Indexed keywords

HEPATITIS C; HUMAN; REVIEW;

HEPATITIS C; HUMANS;

EID: 0030635787     PISSN: 13520504     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2893.1997.00120.x     Document Type: Review

References (240)

1. Koff RS, Dienstag JL. Extrahepatic manifestations of hepatitis C and the association with alcohol liver disease. Semin Liver Dis 1995, 15: 101-109.
2. Nowicki MJ, Balisteri WF. The hepatitis C virus: identification, epidemiology, and clinical controversies. J Pediatr Gastroenterol Nutr 1995; 20: 248-274.
3. Gumber SC, Chopr S. Hepatitis C: A multifaced disease. Review of extrahepatic manifestations. Ann Intern Med 1995; 123: 615-620.
4. Berris B, Feiman V. Thyroid dysfunction and liver injury following alpha interferon treatment of chronic viral hepatitis. Dig Dis Sci 1991; 36: 1657-1660.
5. Lisker-Melman M, Di Bisceglie AM, Usala SJ, Weintraub B, Murray LM, Hoofnagle JH. Development of thyroid disease during therapy of chronic viral hepatitis with interferon alpha. Gastroenterology 1992; 102: 2155-2160.
6. Baudin E, Marcellin P, Pouteau M et al. Reversibility of thyroid dysfunction induced by recombinant alpha interferon in chronic hepatitis C. Clin Endocrinol 1993; 39: 657-661.
7. Marcellin P, Pouteau M, Renard P et al. Sustained hypothyroidism induced by recombinant alpha interferon in patients with chronic hepatitis C. Gut 1992; 33: 855-856.
8. Tran A, Quaranta JF, Benzaken S et al. High prevalence of thyroid autoantibodies in a prospective series of patients with chronic hepatitis C before interferon therapy. Hepatology 1993; 18: 253-257.
9. Tran A, Quaranta JF, Beusnel C et al. Hepatitis C virus and Hashimoto's thyroiditis. Eur J Med 1992; 1: 116-118.
10. Duclos-Valee JC, Johanet C, Duron F, Pateron D, Homberg JC, Beaugrand M. Prevalence elevee des anticorps anti-HCV chez les malades atteints de maladie de Hashimoto. Gastroenterol Clin Biol 1992; 16: A224 (abstract).
11. Pateron D, Hartmann DJ, Duclos Valee JC, Jouanolle H, Beaugrand M. Latent autoimmune thyroid disease in patients with chronic HCV hepatitis. J Hepatol 1992; 16: 244-245.
12. Quaranta JR, Tran A, Regnier D et al. High prevalence of antibodies to hepatitis C virus (HCV) in patients with anti-thyroid autoantibodies. J Hepatol 1993; 18: 136-138.
13. Pawlotsky JM, Ben Yahia M, Andre C et al. Immunological disorders in C virus chronic active hepatitis: a prospective case-control study. Hepatology 1994; 19: 841-848.
14. Allison MED, Wreghitt T, Palmer CR, Alexander GJM. Evidence for a link between hepatitis C virus infection and diabetes mellitus in a cirrhotic population. J Hepatol 1994; 21: 1135-1139.
15. Uzunalimoglu O, Sipahi N, Dokmeci A et al. A link between hepatitis C infection and diabetes mellitus in a Mediterranean population. J Hepatol 1995; 23 (Suppl. 1): 179 (abstract).
16. Haddad J, Deny P, Munz-Gotheil C et al. Lymphocytic sialadenitis of Sjogren's syndrome associated with chronic hepatitis C virus liver disease. Lancet 1992; 339: 321-323.
17. Pirisi M, Scott C, Fabris C et al. Mild sialadenitis: a common finding in patients with hepatitis C virus infection. Scand J Gastroenterol 1994; 29: 940-942.
18. Wilson SE, Lee WM, Murakami C, Weng J, Moninger GA. Mooren's corneal ulcers and hepatitis C virus infection. N Engl J Med 1993; 329: 62.
19. Wilson SE, Lee WM, Murakami C, Weng J, Moninger GA. Mooren-type hepatitis C virus associated corneal ulceration. Opthalmology 1994; 101: 736-745.
20. Grateau G, Bachmeyer C, Malek N, Jublanc C, Caputo G, Renard G. Mooren-type hepatitis C virus-associated corneal ulceration. Eur J Int Med 1995; 6 (Suppl. 1): 24 (abstract).
21. Disdier P, Bolla G, Veit V et al. Association of uveitis and hepatitis C: 5 cases. Presse Med 1994; 23: 561 (letter).
22. Ferri C, Greco F, Longombardo G et al. Association between hepatitis C virus infection in patients with essential mixed cryoglobulinaemia. Ann Intern Med 1992; 117: 573-577.
23. Agnello V, Chung RT, Kaplan LM. A role for hepatitis C virus infection in type II cryoglublinaemia. N Engl J Med 1992; 327: 1490-1495.
24. Misiani R, Bellavita P, Fenili D et al. Hepatitis C virus infection in patients with essential mixed cryoglobulinaemia. Ann Intern Med 1992; 117: 573-577.
25. Dammaco F, Sansonno D. Antibodies to hepatitis C virus in essential mixed cryoglobulinaemia. Clin Exp Immunol 1992; 87: 352-356.
26. Hibbs JR, Issaragrisil S, Young NS. High prevalence of hepatitis C viremia among aplastic anemia patients and controls from Thailand. Ann J Trop Med Hyg 1992; 46: 564-570.
27. Gruber A, Grillner L, Norder H, Magnius L, Biorkholm M. Severe aplastic anemia associated with seronegative community-acquired hepatitis C virus infection. Ann Hematol 1993; 66: 157-159.
28. Durand JM, Lefevre P, Telle H, Kaplanski G, Guiles N, Soubeyacand J. Thrombocytopenic purpura and hepatitis C virus infection. Haematologia 1993; 78: 135.
29. Durand JM, Cretel E, Retornaz F, Lefevre P, Kaplanski G, Soubeyrand J. Alpha interferon therapy in thrombocytopenia associated with hepatitis C virus infection. J Hepatol 1994; 21: 277-278.
30. Ferri C, Monti M, La Civita L et al. Hepatitis C virus infection in non-Hodgkin's B-cell lymphoma complicating mixed cryoglobulinaemia. Eur J Clin Invest 1994; 24: 781-784.
31. Zignego AL, Ferri C, Giannini C et al. HCV infection in B-cell non-Hodgkin's lymphoma. J Hepatol 1995; 23 (Suppl. 1): 77 (abstract).
32. Franzin F, Ebremov D, Pozzato G, Pussini E, Tulissi P, Burrone O. Monoclonal B-cell expansion, non-Hodgkin's lymphomas and HCV infection. J Hepatol 1995; 23 (Suppl. 1): 89 (abstract).
33. De Vita S, Sansonno D, Dolcetti R et al. Hepatatis C virus within a malignant lymphoma lesion in the course of type II mixed cryoglobulinaemia. Blood 1995; 86: 1887-1892.
34. Rollino C, Roccatello D, Giachino O, Basolo B, Piccoli G. Hepatitis C virus infection and membranous glomerulonephritis. Nephron 1991; 59: 319-320.
35. Johnson RJ, Gretch Dr, Yamabe H et al. Membranoproliferative glomerulonephritis associated with hepatitis C virus infection. N Engl J Med 1993; 328: 465-470.
36. Burstein DM, Rodby RA. Membranoproliferative glomerulonephritis associated with hepatitis C virus infection. J Am Soc Nephrol 1993; 4: 1288-1293.
37. Arai H, Tanaka M, Ohta K, Kojo T, Niijima K, Imawari M. Symptomatic myopathy associated with interferon therapy for chronic hepatitis C. Lancet 1995; 345: 582 (letter).
38. Dale JK, DiBisceglie AM, Hoofnagle JH, Straus SE. Chronic fatigue syndrome: lack of association with hepatitis C virus infection. J Med Virol 1991; 34: 119-221.
39. Horsmans Y, Geubel AP. Symptomatic myopathy in hepatitis C infection without interferon therapy. Lancet 1995; 345: 1236 (letter).
40. Ripault MP, Dumas P, de Ledinghen V, Silvain C, Beauchant M. Peripheral neuropathy related to HCV infection. Hepatology 1995; 22 (No. 4 Pt. 2): 480A (abstract).
41. Sawada T, Hirohata S, Inoue T, Ito K. Development of rheumatoid arthritis after hepatitis C virus infection. Arthritis Rheum 1991; 34: 1920-1921.
42. Borque L, Elena A, Maside C, Rus A, Del Cura J. Rheumatoid arthritis and hepatitis C virus antibodies. Clin Exp Rheumatol 1991; 9: 617-619.
43. Durand JM, Lefevre P, Harle JR, Boucrat J, Vitviski L, Soubeyrand J. Cutaneous vasculitis and cryoglobulinaemia type II associated with hepatitis C virus infection. Lancet 1991; 337: 499-500 (letter).
44. Pakula AS, Garden JM, Roth SI. Cryogloublinemia and cutaneous leukocytoclastic vasculitis associated with hepatitis C virus infection. J Am Acad Dermatol 1993; 28: 850-853.
45. Daoud MS, Gibson LE, Daoud S, El-Azhary RA. Chronic hepatitis C and skin diseases: a review. Mayo Clin Proc 1995; 1995: 559-564.
46. Fargion S, Piperno A, Cappellini MD et al. Hepatitis C virus and porphyria cutanea tarda: evidence of a strong association. Hepatology 1992; 16: 1322-1326.
47. De Castro M, Sanchez J, Herrera JF et al. Hepatitis C virus antibodies and liver disease in patients with porphyria cutanea tarda. Hepatology 1993; 17: 551-557.
48. Mokni M, Rybojad M, Puppin D Jr et al. Lichen planus and hepatitis C virus. J Am Acad Dermatol 1991; 24: 792.
49. Agner T, Fogh H, Weismann K. The relation between lichen planus and hepatitis C: a case report. Acta Dermatol Venereol 1992; 72: 380.
50. Santander C, DeCastro M, Garcia-Monzon C et al. Prevalance of hepatitis C virus infection and liver damage in patients with lichen planus. Hepatology 1994; 20: 238 A (abstract).
51. Antinori S, Esposito R, Aliprandi CA, Tadini G. Erythema multiforme and hepatitis C. Lancet 1991; 337: 428 (letter).
52. Domingo P, Ris J, Martinez E, Casas F. Erythema nodosum and hepatitis C. Lancet 1990; 336: 1377.
53. Bodokh I, Lacour JP, Perrin C et al. Cutaneous malacoplakia associated with chronic hepatitis caused by hepatitis C virus. Ann Dermatol Venereol 1993; 120: 808-810.
54. Reichel M, Mauro TM. Urticaria and hepatitis C. Lancet 1990; 336: 822-823 (letter).
55. Fisher DA, Wright TL. Pruritus as a symptom of hepatitis C. J Am Acad Dermatol 1994; 30: 629-632.
56. Quint L, Deny P, Guillevin L et al. Hepatitis C virus in patients with polyarteritis nodosa: prevalence in 38 patients. Clin Exp Rheumatol 1991; 9: 253-257.
57. Cacoub P, Lunel-Fabiani F, Du LT. Polyarteritis nodosa and hepatitis C virus infection. Ann Intern Med 1992; 116: 605-606 (letter).
58. Carson CW, Conn DL, Czaja AJ, Wright TL, Brecher ME. Frequency and significance of antibodies to hepatitis C virus in polyarteritis nodosa. J Rheumatol 1993; 20: 304-309.
59. Ueda T, Ohta K, Suzuki N, Yamaguchi M, Hirai K, Horiuchi T. Idiopathic pulmonary fibrosis and high prevalence of serum antibodies to hepatitis C virus. Am Rev Respir Dis 1992; 146: 266-268.
60. Roithinger FX, Allinger S, Kirchgatterer A et al. A lethal course of chronic hepatitis C, glomerulonephritis, and pulmonary vasculitis unresponsive to interferon treatment. Am J Gastroenterol 1995; 90: 1006-1008.
61. Prieto J, Yuste JR, Beloqui O et al. Anticardiolipin antibodies in chronic hepatitis C: implication of hepatitis C virus as the cause of the antiphospholipid syndrome. Hepatology 1996; 23: 199-204.
62. Al-Saeed A, Makris M, Malia RG et al. The development of antiphospholipid antibodies in haemophilia is linked to infection with hepatitis C. Br J Haematol 1994; 88: 845-848.
63. Yamamoto S, Iguchi Y, Ohomoto K, Mitsui Y, Shimabara M, Mikami Y. Epitheloid granuloma formation in type C chronic hepatitis: report of two cases. Hepato-Gastroenterol 1995; 42: 291-293.
64. Okuno T, Aral K, Matsumoto M, Shindo M. Epithelioid granulomas in chronic hepatitis C: A transient pathological feature. J Gastroenterol Hepatol 1995; 10: 532-537.
65. Bianchi FB. Autoimmune hepatitis: the lesson of the discovery of hepatitis C virus. J Hepatol 1993; 18: 273-275.
66. Maddrey WC. How many types of autoimmune hepatitis are there? Gastroenterology 1993; 105: 1571-1575.
67. Vergani D, Mieli-Vergani G. Type II autoimmune hepatitis. What is the role of the hepatitis C virus? Gastroenterology 1993; 104: 1870-1873.
68. Czaja AJ. Autoimmune hepatitis and viral infection. Gastroenterol Clin N Am 1994; 23: 547-566.
69. Clifford BD, Donahue D, Smith L et al. High prevalence of serological markers of autoimmunity in patients with chronic hepatitis C. Hepatology 1995; 21: 613-619.
70. Pawlotsky J-M, Roudot-Thoraval F, Simmonds P et al. Extrahepatic immunologic manifestations in chronic hepatitis C and hepatitis C virus serotypes. Ann Intern Med 1995; 122: 169-173.
71. Pontisso P, Ruvoletto MG, Fattovich G et al. Clinical and virological profiles in patients with multiple hepatitis virus infections. Gastroenterology 1993; 105: 1529-1533.
72. Feray C, Gigou M, Samuel D et al. Hepatitis C virus RNA and hepatitis B virus DNA in serum and liver of patients with fulminant hepatitis. Gastroenterology 1993; 104: 549-555.
73. Kaklamani E, Trichopoulos D, Tzonou A et al. Hepatitis B and C viruses and their interaction in the origin of hepatocellular carcinoma. J Am Med Assoc 1991; 265: 1974-1976.
74. Hadziyannis SJ, Giannoulis G, Hadziyannis E et al. Hepatitis C virus infection in Greece and its role in chronic liver disease and hepatocellular carcinoma. J Hepatol 1993; 17 (Suppl. 3) S72-S77.
75. Hadziyannis S, Wages J, Kim JP et al. Frequency of viraemia with a new hepatitis virus (HGV) in patients with liver disease and in groups at high risk of exposure to blood and blood products. J Hepatol 1995; 23 (Suppl. 1): 78 (abstract).
76. Hadziyannis SJ, Dawson GJ, Vrettou E, Gioustozi A, Schlauder G, Desai S. Infection with the novel GB-C virus in multiply transfused patients and in various forms of chronic liver disease. Hepatology 1995; 22 (No. 4 Pt.2): 218A (abstract).
77. Linnen J, Wages J Jr, Zhang-Keck Z-Y et al. Molecular cloning and disease association of hepatitis G virus: A transfusion-transmissible agent. Science 1996; 271: 505-508.
78. Hayashi PH, Flynn N, McCurdy SA, Kuramoto IK, Holland PV, Zeldis JB. Prevalence of hepatitis C virus antibodies among patients infected with human immunodeficiency virus. J Med Virol 1991; 33: 177-180.
79. McNair ANB, Main J, Thomas HC. Interactions of the human immunodeficiency virus and the hepatotropic viruses. Semin Liver Dis 1992; 12: 188-196.
80. Wright TL, Hollander H, Pu X et al. Hepatitis C in HIV-infected patients with and without AIDS: prevalence and relationship to patient survival. Heapatology 1994; 20: 1152-1155.
81. Guido M, Rugge M, Fattovich G et al. Human immunodeficiency virus infection and hepatitis C pathology. Liver 1991; 14: 314-319.
82. Abeck D, Brandt O, Weichenthal M, Kowalzick L, Mensing H. Chronic mucocutaneous herpes simplex infection. Occurrence within the scope of liver-induced immunodeficiency. Hautarzt 1993; 44: 670-673.
83. Kamel MA, Miller FD, el Masry AG, Zakarias S, Khattab M, Essmat G, Ghaffar YA. The epidiemiology of schistosoma mansoni, hepatitis B and hepatitis C infection in Egypt. Ann Trop Med Parasitol 1994; 88: 501-509.
84. Koshy A, al Nakib B, al Mufti S, Madda JP, Hira PR. Anti-HCV-positive cirrhosis associated with schistosomiasis. Am J Gastroenterol 1993; 88: 1428-1431.
85. Mendenhall CL, Seef L, Diehl AM et al. The VA Cooperative Study Group (No. 119). Antibodies to hepatitis B virus and hepatitis C virus in alcoholic hepatitis and cirrhosis: their prevalence and clinical relevance. Hepatology 1991; 14: (Pt.1): 581-589.
86. Fong T-L, Kanel GC, Conrad A, Valinluck B, Charboneau F, Adkins RH. Clinical significance of concomitant hepatitis C infection in patients with alcoholic liver disease. Hepatology 1994; 19: 554-557.
87. Zignego AL, Foschi M, Laffi G et al. 'Inapparent' hepatitis B virus infection and hepatitis C virus replication in alcoholic subjects with and without liver disease. Hepatology 1994; 19: 577-582.
88. Yokoyama H, Ishii H, Moriya S et al. Relationship between hepatitis C virus subtypes and clinical features of liver disease seen in alcoholics. J Hepatol 1995; 22: 130-134.
89. von Weizsacker F, Maeda E, Brown N et al. Hepatitis B and C virus infection in HBsAg-negative alcoholics without i.v. drug abuse or previous blood transfusions. Intern Hepatol Commun 1995; 4: 80-87.
90. van den Hock JA, van Haastrecht HJ, Goudsmit J, de Wolf F, Coutinho RA. Prevalence, incidence, and risk factors of hepatitis C virus infection among drug users in Amsterdam. J Infect Dis 1990; 162: 823-826.
91. Tibbs CJ. Methods of transmission of hepatitis C. J Viral Hep 1995; 2: 113-119.
92. Rodriguez M, Riestra S, San Roman F et al. Prevalence of antibody to hepatitis C virus in acute non-A, non-B hepatitis in patients from different epidemiological categories. Arch Virol 1992; 4(Suppl.): 319-320.
93. Olynyk JK, Rajender Reddy K, Di Bisceglie AM et al. Hepatic iron concentration as a predictor of response to Interferon alfa therapy in chronic hepatitis C. Gastroenterology 1995; 108: 1104-1109.
94. Barton AL, Banner BF, Cable EE, Bonkovsky HL. Distribution of iron in the liver predicts the response of chronic hepatitis C infection to interferon therapy. Am J Clin Pathol 1995; 103: 419-424.
95. Farinati F, Cardin R, De Maria N et al. Iron storage, lipid peroxidation and glutathione turnover in chronic anti-HCV positive hepatitis. J Hepatol 1995; 22: 449-456.
96. Zeldis JB, Depner TA, Kuramoto IK, Gish RG, Holland PV. The prevalence of hepatitis C virus antibodies among hemodialysis patients. Ann Intern Med 1990; 112: 958-960.
97. Sakamoto N, Enomoto N, Marumo F, Sato C. Prevalence of hepatitis C virus infection among long-term hemodialysis patients: detection of hepatitis C virus RNA in plasma. J Med Virol 1993; 39: 11-15.
98. Okuda K, Hayashi H, Kobayashi S, Irie Y. Mode of hepatitis infection not associated with blood transfusion among chronic hemodialysis patients. J Hepatol 1995; 23: 28-31.
99. Hou CH, Chen WY, Kao JH et al. Intrafamilial transmission of hepatitis C virus in hemodialysis patients. J Med Virol 1995; 45: 381-385.
100. Mangia A, Cascavilla L, Musto P et al. Hepatitis C virus infection in patients with monoclonal gammopathy. J Hepatol 1995; 23(Suppl. 1): 188 (abstract).
101. Rodriquez-Rosado R, Belogui O, Fernandez J, Inoges S, Prieto J. Detection of anticardiolipin antibodies and β-2-GPI in cryoprecipitate of patients with chronic hepatitis C and cryoglobulinemia. J Hepatol 1995; 23 (Suppl. 1): 95 (abstract).
102. Hollo G, Szalay F, Nemesanszky E. Dry eye syndrome in chronic hepatic diseases. J Hepatol 1995; 23(Suppl. 1): 250 (abstract).
103. Perez-Calvo, Torralba MA, Cebollada J, Morandeira MJ, Otal I, Barrao F. Chronic C hepatitis and coincidental liver granulomatosis. Eur J Intern Med 1995; 6 (Suppl. 1): 13 (abstract).
104. Huang M-J, Liaw Y-F. Clinical associations between thyroid and liver diseases. J Gastroenterol Hepatol 1995; 10: 344-350.
105. Golding P, Smith M, William R. Multisystem involvement in chronic liver disease. Am J Med 1973; 55: 772-782.
106. Crowe JP, Christensen E, Buttler J et al. Primary biliary cirrhosis: The prevalence of hypothyroidism and its relationship to thryroid autoantibodies and sicca syndrome. Gastroenterology 1980; 78: 1437-1441.
107. Huang MJ, Chien RN, Tsai SL, Liaw YF. High prevalence of thyroid autoantibodies in patients with chronic hepatitis C. Int Hepatol Commun 1995; 3 (Suppl.): 550.
108. Marcellin P, Pouteau M, Benhamou J-P. Hepatitis C virus infection, alpha interferon therapy and thyroid dysfunction. J Hepatol 1995; 22: 364-369.
109. Di Bisceglie AM, Martin P, Kassianides C et al. Recombinant alpha interferon therapy for chronic hepatitis C. A randomized, double-blind, placebo-controlled trial. N Engl J Med 1989; 321: 1506-1510.
110. Boadas J, Rodriguez-Espinosa J, Enriquez J et al. Prevalence of thyroid autoantibodies is not increased in blood donors with hepatitis C virus infection. J Hepatol 1995; 22: 611-615.
111. Durazzo M, Gallone G, Scaglione L et al. HCV infection and thyroid dysfunction. Fifth International Symposium on Hepatitis C Virus and Related Viruses. Gold Coast, 28 August-3 September, Australia 1995; C244 (abstract).
112. Paggi A, Leri O, Taliani G et al. Hepatitis C virus and autoimmune thyroid diseases. Possible non coincidential association. Eur J Int Med 1995; 6: 33-36.
113. Marcellin P, Benhamou J-P. Autoimmune disorders associated with hepatitis C. In: Boyer JL, Ockner RK, eds. Progress in Liver Diseases. Philadelphia: WB Saunders, 1995; vol XIII: 247-267.
114. Fattovich G, Giustina G, Favarato S, Ruol A. Investigators of the Italian Association for the Study of the Liver. A study of adverse events in 11 241 patients with chronic viral hepatitis treated with alfa interferon. J Hepatol 1996; 24: 38-47.
115. Murakami T, Masumoto T, Michitaka K et al. Prediction of interferon-alpha-induced thyroid dysfunction in patients with chronic hepatitis C. J Gastroenterol Hepatol 1995; 10: 523-527.
116. Serejo F, Gloria H, Marinho R, Raimundo M, Ramalho F, Carneiro de Moura M. Autoimmunity and thyroid dysfunction in chronic hepatitis treated with interferon. Hepatology 1995; 22 (No.4 Pt.2): 351A (abstract).
117. Kodama T, Katabami S, Kamijo K et al. Development of transient thyroid disease and reaction during treatment of chronic hepatitis C with interferon. J Gastroenterol 1994; 29: 289-292.
118. Watanabe U, Hashimoto E, Hisamitsu T, Obata H, Hayashi N. The risk factor for development of thyroid disease during interferon-α therapy for chronic hepatitis C. Am J Gastroenterol 1994; 89: 399-403.
119. Tran A, Braun HB, Benzken S et al. Anti-GOR and anti-thyroid autoantibodies in patients with chronic hepatitis C. Gastroenterology 1994; 106: A999.
120. Mason AL, Lau JYN, Oian KP et al. Association of diabetes mellitus with chronic hepatitis C virus (HCV) infection. Hepatology 1995; 22 (No.4 Pt.2): 351A (abstract).
121. Fabris P, Betterle C, Floreani A et al. Development of type 1 diabetes mellitus during interferon alfa therapy for chronic HCV hepatitis. Lancet 1992; 340: 548 (letter).
122. Daruich JR, Zas M, Findor JA, Santarelli MT, Demetrio C, Bar J. Lacrimal disfunction in patients with chronic HCV infection. Hepatology 1995; 22 (No.4 Pt.2): 406A (abstract).
123. Pemey P, Jorgensen C, Legouffe MC et al. Prospective study of primary Sjogren syndrome associated to HCV-infected patients: Clinical, immunological, genetical and viral genotype characteristics. Hepatology 1995; 22 (No.4 Pt.2): 352A (abstract).
124. Wang J-T, Want T-H, Sheu J-C, Lin J-T, Chen D-S. Hepatitis C virus RNA in saliva of patients with post-transfusion hepatitis and low efficiency of transmission among spouses. J Med Virol 1992; 36: 28-31.
125. Mariette X, Loiseasu P, Morinet F. Hepatitis C virus in saliva. Ann Intern Med 1995; 122: 556.
126. King PD, McMurray RW, Becherer PR. Sjogren's syndrome without mixed cryoglublinemia is not associated with hepatitis C virus infection. Am J Gastroenterol 1994; 89: 1047-1050.
127. Slepova OS, Kushnir VN, Zaitseva NS, Titarenko ZD, Dumbrava VA. Clinical and immunological signs of retinal lesions and possibilities of their correction by drugs in patients with chronic diffuse liver diseases of viral etiology and carriers of Australia antigen. Vestn Oftalmol 1994; 110: 27-29.
128. Singh VK, Kalra HK, Yamaki K, Abe T, Donoso LA, Shinohara T. Molecular mimicry between a uveitopathogenetic site of S-antigen and viral peptides. Induction of experimental autoimmune uveitis in Lewis rats. J Immunol 1990; 144: 1282-1287.
129. Shinohara T, Singh VK, Tsuda M, Yamaki K, Abe T, Suzuki S. S-antigen: from gene to autoimmune uveitis. Exp Eye Res 1990; 50: 751-757.
130. Bouffard P, Hayashi PH, Acevedo R, Levy N, Zeldis JB. Hepatitis C virus is detected in a monocyte/macrophage subpopulation of peripheral blood mononuclear cells of infected patients. J Infect Dis 1992; 166: 1276-1280.
131. Ferri C, Monti M, La Civita L et al. Infection of peripheral cells by hepatitis C virus in mixed cryoglobulinemia. Blood 1993; 38: 3701-3704.
132. Shimizu YK, Feinstone SM, Kohara M, Purcell RH, Yoshikura H. Hepatitis C virus: Detection of intracellular virus particles by electron microscopy. Hepatology 1996; 23: 205-209.
133. Branch AD. Replication of hepatitis C virus: Catching it in the act. Hepatology 1996; 23: 372-375 (editorial).
134. Agnello V, Abel G, Knight GB et al. Detection of hepatitis C virus (HCV) in liver, bone marrow, and lymph nodes in type II mixed cryoglobulinemia (MC) using in situ hybridization. Fifth International Symposium on Hepatitis C Virus and Related Viruses. Gold Coast, 28 August-3 September, Australia 1995: C163 (abstract).
135. Galli M, Zehender G, Monti G et al. Hepatitis C virus RNA in the bone marrow of patients with mixed cryoglobulinemia and in subjects with noncryoglublinemia chronic hepatitis type C. J Infect Dis 1995; 171: 672-675.
136. Abel G, Knight GB, Agnello V. Hepatitis C virus (HCV) infection of keratinocytes of vasculitis lesions in type II cryoglobulinemia (MC). Fifth International Symposium on Hepatitis C Virus and Related Viruses. Gold Coast, 28 August-3 September, Australia 1995: C152 (abstract).
137. Freni MA, Artuso D, Gerken G et al. Focal lymphocytic aggregates in chronic hepatitis C: occurrence, immunohistochemical characterization, and relation to markers of autoimmunity. Hepatology 1995; 22: 389-394.
138. Meltzer M, Franklin E. Cryoglobulinemia: A study of twenty-nine patients. I. IgG and IgM cryoglobulins and factors affecting cryoprecipitability. Am J Med 1966; 40: 828-836.
139. Ferri C, Monti M, Lo Jacono F et al. Infection by HCV and other lymphotropic viruses in B-cell non-Hodgkin's lymphoma. J Hepatol 1995; 25 (Suppl. 1): P/C1/47 (abstract).
140. Ferri C, La Civita L, Monti et al. Can type C hepatitis infection by complicated by malignant lymphoma? Lancet 1995; 346: 1426-1427 (letter).
141. Hartmann H, Schott P, Polzien F, Mihm S, Ramadori G. Cryoglobulinemia in chronic hepatitis C virus infection: is cross-reactivity of anti-HCV IgM to IgG a pathogenetic mechanism? J Hepatol 1995; 25 (Suppl. 1): WP 1/05 (abstract).
142. Levo Y, Gorevic PD, Kassab HJ, Tobias H, Franklin EC. Liver involvement in the syndrome of mixed cryoglobulinemia. Ann Intern Med 1977; 87: 287-292.
143. Hijikata M, Shimizu YK, Kato H et al. Equilibrium centrifugation studies of hepatitis C virus: Evidence for circulating immune complexes. J Virol 1993; 67: 1953-1958.
144. Casato M, Taliani G, Pucillo LP, Goffredo F, Lagana B, Bononio L. Cryoglublinemia and hepatitis C virus. Lancet 1991; 337: 1047-1048.
145. Pascual M, Perrin L, Giostra E, Schifferli JA. Hepatitis C virus in patients with cryoglobulinemia type II. J Infect Dis 1990; 162: 569-570.
146. Marcellin P, Descamps V, Martinot-Peignoux M et al. Cryoglobulinemia with vasculitis associated with hepatitis C virus infection. Gastroenterology 1993; 104: 272-277.
147. Lunel F, Musset L, Cacoub P et al. Cryoglobulinemia in chronic liver diseases: Role of hepatitis C virus and liver damage. Gastroenterology 1994; 106: 1291-1300.
148. Mazzaro C, Tulissi P, Moretti et al. Clinical and virological findings in mixed cryoglublinaemia. J Int Med 1995; 238: 153-160.
149. Lenzi M, Frisoni M, Mantovani V et al. HLA-B8 confers susceptibility to HCV-related mixed cryoglubulinaemia. Hepatology 1995; 22 (No.4 Pt.2): 353A (abstract).
150. Aiyama T, Yoshioka K, Okumura et al. Sequence analysis in hypervariable region of HCV in cryoblobulins with chronic HCV disease. Hepatology 1995; 22 (No.4 Pt.2): 353A (abstract).
151. Zignego AL, Cursaro C, Gramenzi A et al. Hepatitis C virus infection and monoclonal gammopathy (MG): Possible role of genotype 2a. Hepatology 1995; 22 (No.4 Pt.2): 353A (abstract).
152. Zignego AL, Ferri C, Giannini C et al. Hepatitis C virus genotype analysis in patients with type II mixed cryoglobulinemia. Ann Intern Med 1996; 124: 31-34.
153. Kakumu S, Tanaka K, Aiyama T, Imai J, Morishita Y, Fukatsu T. Serum cryoglobulins and chronic hepatitis C virus. Disease among Japanese patients. Hepatology 1995; 22 (No.4 Pt.2): 435A (abstract).
154. Lunel F, Frangeul L, Poynard T et al. Multivariate analysis of the potential factors involved in the production of cryoglobulins in HCV infected patients. Hepatology 1995; 22 (No.4 Pt.2): 449A (abstract).
155. Van Thiel DH, Fagiuoli S, Caraceni P et al. Cryoglobulinemia: a cause for false negative polymerase chain reaction results in patients with hepatitis C virus positive chronic liver disease. J Hepatol 1995; 22: 464-467.
156. Ballare M, Bertoncelli MC, Gnemmi P et al. Presence and evolution of liver lymphoid aggregates in HCV-associated type II mixed cryoglobulinemia. Fifth International Symposium on Hepatitis C Virus and Related Viruses. Gold Coast, 28 August-3 September, Australia 1995: C45 (abstract).
157. Kakumu S, Alyama T, Yoshioka K et al. Cryoglobulinemia and chronic hepatitis C virus disease among Japanese patients. Intern Hepatol Commun 1995; 3 (Suppl.): S49.
158. Cacoub P, Frangeul L, Lunel F et al. Mixed cryoglobulinemia and hepatitis C virus infection: A multivariate analysis. Eur J Intern Med 1995; 6 (Suppl.): 54 (abstract).
159. Schirren C-A, Zachoval R, Schirren C-G, Gerbes AL, Pape GR. A role for chronic hepatitis C virus infection in a patient with cutaneous vasculitis, cryoglobulinemia, and chronic liver disease. Dig Dis Sci 1995; 40: 1221-1225.
160. Zenda T, Okamoto R, Sanada H et al. A possible pathogenic relation between hepatitis C virus and essential cryoglobulinemia, rheumatoid factor and consumption of complement following interferon-beta therapy for chronic active hepatitis C. Acta Hepatol Japan 1995; 36: 381-385.
161. Martins A, Goncalves G, Costa A, Ribeiro S, Reis A. Mixed cryoglobulinemia type III associated to chronic hepatitis C virus infection. Eur J Intern Med 1995; 6 (Suppl. 1): 71 (abstract).
162. Misiani R, Bellavita P, Fenili D et al. Interferon alfa-2a therapy in cryoglobulinemia associated with hepatitis C virus. N Engl J Med 1994; 330: 751-756.
163. Peters M, Trippler M, Lohr H et al. Posttransfusional, LKM-1-autoantibody-positive hepatitis C virus infection, cryoglobulinemia, and aplastic anemia. Dig Dis Sci 1995; 40: 763-773.
164. Pol S, Driss F, Devergie A et al. Is hepatitis C virus involved in hepatitis-associated aplastic anemia: Ann Intern Med 1990; 113: 435-437.
165. Hibbs JR, Frickhofen N, Rosenfeld SJ et al. Aplastic anemia and viral hepatitis: Non-A, non-B, non-C? J Am Med Assoc 1992; 267: 2051-2054.
166. Myerson D, Kiem H-P, Spurgeon CL, McDonald GB. Hepatitis-associated aplastic anemia: Virologic studies and long-term follow-up. Hepatology 1995; 22 (No.4 Pt.2): 461A (abstract).
167. Pawlotsky J-M, Bouvier M, Fromont P et al. Hepatitis C virus infection and autoimmune thrombocytopenic purpura. J Hepatol 1995; 23: 635-639.
168. Pereira J, Accantino L, Alfaco J, Brahm J, Hidalgo P, Mezzano D. Platelet antibodies in patients with chronic liver disease. Am J Hematol 1995; 50: 173-178.
169. Kajiwara E. Akagi K, Azuma K, Onoyama K. Fujishima M. Evidence for an immunological pathogenesis of thrombocytopenia in chronic liver disease. Am J Gastroenterol 1995; 90: 962-966.
170. Nagamine T, Ohtuka T, Takehara K, Arai T, Takagi H, Mori M. Thrombocytopenia associated with hepatitis C viral infection. J Hepatol 1996; 24: 135-140.
171. Shrestha R, McKinley C, Bilir BM, Everson GT. Possible idiopathic thrombocytopenic purpura associated with natural alpha interferon therapy for chronic hepatitis C infection. Am J Gastroenterol 1995; 90: 1146-1147.
172. Bordin G, Ballare M, Bertoncelli MC, Paccagnino L, Zigrossi P, Monteverde A. HCV-associated thrombocytopenia, thrombokinetic study. Fifth International Symposium on Hepatitis C Virus and Related Viruses. Gold Coast, 28 August-3 September, Australia 1995: C151 (abstract).
173. Dourakis S, Deutsch M, Hadziyannis S. Immune thrombocytopenia and a-interferon therapy. J Hepatol 1996; 25: in press.
174. Sechi LA, Pirisi M, Bartoli E. Membranoproliferative glomerulonephritis associated with hepatitis C infection with no evidence of liver disease. J Am Med Assoc 1994; 271: 194 (letter).
175. Arai H, Tanaka M, Ohta K, Kojo T, Niijima K, Imawari M. Symptomatic myopathy associated with interferon therapy for chronic hepatitis C. Lancet 1995; 345; 582 (letter).
176. Halfon P, Levy M, San Marco M et al. Myasthenia gravis and hepatitis C virus infection. Hepatology 1995; 22 (No.4 Pt.2): 425A (abstract).
177. Batocchi AP, Evoli A, Servidei S et al. Myasthenia Gravis during interferon alfa therapy. Neurology 1995; 45: 382-383.
178. Harada M, Sata M, Yoshida H et al. Inflammatory myopathy associated with hepatitis C virus infection: a report of four cases. Int Hepatol Commun 1995; 4: 195-200.
179. Russo GG, Millikan LE. Dermatologic disorders associated with hepatitis infections. Int J Dermatol 1996; 35: 77-81.
180. Theilmann L, Gmelin K, Kallinowski B, Kommerell B, Koderisch J, Andrassy K. Prevalence of antibodies to hepatitis C virus in sera from patients with systemic necrotizing vasculitis. Nephron 1991; 57: 482 (letter).
181. Hearth-Holmes M, Zahradka S, Baethge BA, Wolf RE. Leukocytoclastic vasculitis associated with hepatitis C. Am J Med 1991; 90: 765-766 (letter).
182. Remond B, Reygagne P, Aractingi S, Dubertrer L. Vascularite cutance avec cryoglobulinemie mixte au cours d'une hepatite chronique C. Ann Dermatol Venereol 1992; 119: 827-829.
183. Durand JM, Kaplanski G, Richard MA et al. Cutaneous vasculitis in a patient infected with hepatitis C virus: detection of hepatitis C virus RNA in the skin by polymerase chain reaction. Br J Dermatol 1993; 128: 359-360 (letter).
184. Zimmerman R, Konig V, Bauditz J, Hopf U. Interferon alfa in leukocytoclastic vasculitis, mixed cryoglobulinaemia, and chronic hepatitis C. Lancet 1993; 341: 561-562 (letter).
185. Levey JM, Bjornsson B, Banner B et al. Mixed cryoglobulinemia in chronic hepatitis C infection: a clinicopathologic analysis of 10 cases and review of recent literature. Medicine 1994; 73: 53-67.
186. Ferri C, Zignego AL, Longombardo G et al. Effect of alpha-interferon on hepatitis C virus chronic infection in mixed cryoglobulinemia. Infection 1993; 21: 93-97.
187. Ferri C, Baicchi U, La Civita L et al. Hepatitis C virus-related autoimmunity in patients with porphyria cutanea tarda. Eur J Clin Invest 1993; 23: 851-855.
188. Herrero C, Vicente A, Bruguera M et al. Is hepatitis C virus infection a trigger of porphyria cutanea tarda? Lancet 1993; 314: 788-789.
189. Lacour JP, Bodokh I, Castanet J, Beckri S, Ortonne JP. Porphyria cutanea tarda and antibodies to hepatitis C virus. Br J Dermatol 1993; 128: 121-123.
190. Koester G, Feldman J, Bigler C. Hepatitis C in patients with porphyria cutanea tarda. J Am Acad Dermatol 1994; 31: 1054.
191. Stolzel U, Kostler E, Stoffler-Meilicke M et al. Hepatitis C virus infection in porphyria cutanea tarda in Germany. Gastroenterology 1994; 106: A990 (abstract).
192. Navas S, Bosch O, Castillo I, Marriott E, Carreno V. Porphyria cutanea tarda and hepatitis C and B viruses infection: A retrospective study. Hepatology 1995; 21: 279-284.
193. Kondo M, Horie V, Okano J et al. Porphyria cutanea tarda and HCV infection. Intern Hepatol Commun 1995; 3 (Suppl.): S45.
194. Sampietro M, Francanzani AL, Corbetta N et al. HCV type 1b in patients with chronic liver diseases and porphyria cutanea tarda (PCT). Hepatology 1995; 22 (No.4 Pt.2) 350A (abstract).
195. Rebora A, Rongioletti F. Lichen planus and chronic active hepatitis: A retrospective survey. Acta Dermatol Venereol 1984; 64: 52-56.
196. Doutre MS, Beylot C, Couzigou P, Long P, Royer P, Beylot L. Lichen planus and virus C hepatitis: disappearance of the lichen under interferon alfa therapy. Dermatology 1992; 184: 229 (letter).
197. Strumia R, Venturini D, Boccia S, Gamberini S, Gullini S. UVA and interferon-alfa therapy in a patient with lichen planus and chronic hepatitis C. Int J Dermatol 1993; 32: 386 (letter).
198. Boccia S, Gamberini S, Dalla Libera M, Strumia R, Venturini D. Lichen planus and interferon therapy for hepatitis C. Gastroenterology 1993; 105: 1921-1922 (letter).
199. Cecchi R, Giomi A, Tuci F, Bartoli L, Seghieri G. Pityriasis rubra pilaris, lichen planus, alopecia universalis and vitiligo in a patient with chronic viral hepatitis C. Dermatology 1994; 188: 239-240.
200. Papini M, Bruni PL, Bettacchi A, Liberati F. Sudden onset of oral ulcerative lichen in a patient with chronic hepatitis C on treatment with a-interferon. Int J Dermatol 1994; 33: 221-222 (letter).
201. Protzer U, Ochendorf FR, Leopolder-Ochendorf A, Holtermuller K. Exacerbation of lichen planus during interferon alfa-2a therapy for chronic active hepatitis C. Gastroenterology 1993; 104: 903-905.
202. Barreca T, Corsini G, Franceschini R, Gambini C, Garibaldi A, Rolandi E. Lichen planus induced by interferon-alpha-2a therapy for chronic active hepatitis C. Eur J Gastroenterol Hepatol 1995; 7: 367-368.
203. Rebora A, Robert E, Rongioletti F. Clinical and laboratory presentation of lichen planus patients with chronic liver disease. J Dermatol Sci 1992; 4: 38-41.
204. Divano MC, Parodi A, Rebora A. Lichen planus, liver kidney (LKM-1) microsomal antibodies and hepatitis C virus antibodies. Dermatology 1992; 185: 132-133.
205. Grandolfo S, Carbone M, Carozzo M, Gallo V. Oral lichen planus and hepatitis C virus (HCV) infection: Is there a relationship? A report of 10 cases. J Oral Pathol Med 1994; 23: 119-122.
206. Bellman B, Reddy RK, Falanga V. Lichen planus associated with hepatitis C. Lancet 1995; 346: 1234 (letter).
207. Jubert C, Pawlotsky JM, Pouget F, Andre C, DeForge L, Bretagne S. Lichen planus and hepatitis C virus-related chronic active hepatitis. Arch Dermatol 1994; 130: 73-76.
208. Miinke H, Stockmann F, Ramadori G. Possible association between Behcet's syndrome and chronic hepatitis C virus infection. N Engl J Med 1995; 332: 400-401.
209. Lebovics E, Seif F, Kim D et al. Pruritus in chronic hepatitis C: Association with high serum bile acids, advanced pathology and bile duct abnormalities. Hepatology 1995; 22 (No.4 Pt.2): 350A (abstract).
210. Bonacini M, Govindarajan S. Chronic cholestatic hepatitis C in immunocompromised patients. Hepatology 1995; 22 (No.4 Pt.2): 351A (abstract).
211. Irving SE, Day S, Johnson ID. Idiopathic pulmonary fibrosis and hepatitis C virus infection. Am Rev Resp Dis 1993; 148: 1683-1684.
212. Rodriguez-Rosado R, Belogui O, Fernandez J, Inoges S, Prieto J. Detection of anticardiolipin antibodies and β-2-GPI in cryoprecipitate of patients with chronic hepatitis C and cryoglobulinemia. J Hepatol 1995; 23 (Suppl. 1): 95 (abstract).
213. McNeil HP, Simpson RJ, Chesterman CN, Krilis SA. Antiphospholipid antibodies are directed against a complex antigen that includes a lipid-binding inhibitor of coagulation: beta-2-glycoprotein-1 (apolipoprotein H). Proc Natl Acad Sci USA 1990; 87: 4120-4124.
214. Harris EN, Gharavi AE, Hegde U et al. Anticardiolipin antibodies in autoimmune thrombocytopenic purpura. Br J Haematol 1985; 59: 231-234.
215. McFarlane IG, Smith HM, Johnson PJ, Bray GP, Vergani D, Williams R. Hepatitis C virus antibodies in chronic active hepatitis: pathogenetic factor or false-positive result?Lancet 1990; 335: 754-757.
216. Rowan BP, Smith A, Gleeson D, Hunt LP, Warnes TW. Hepatitis C virus in autoimmune liver disease in the UK: aetiological agent or artifact? Gut 1994; 35: 542-546.
217. Strassburg CP, Manns MP. Autoimmune hepatitis versus viral hepatitis C. Liver 1995; 15: 225-232.
218. Czaja AJ, Carpenter HA, Santrach PJ, Moore SB. Genetic predispositions for immunologic features in chronic liver diseases other than type 1 autoimmune hepatitis. Hepatology 1995; 22 (No.4 Pt.2): 406A (abstract).
219. Sorbara R, Pigozzi MG, Tebaldi P, Franceschini F, Lanzini A. Prevalence of autoantibodies in patients with chronic hepatitis C (CHC): comparison with blood donors. Hepatology 1995; 22 (No.4 Pt.2): 493A (abstract).
220. Bayraktar Y, Bayraktar M, Gurakar A, Hassanein T, Van Thiel DH. Comparison of the prevalence of autoantibodies in chronic hepatitis C patients with those of autoantibodies in autoimmune hepatitis patients. Hepatology 1995; 22 (No.4 Pt.2): 393A (abstract).
221. Reddy KR, Krawitt EL, Homberg J-C et al. Absence of anti-LKM-1 antibody in hepatitis C viral infection in the United States of America. J Viral Hep 1995; 2: 175-179.
222. Yang PM, Sheu JC, Lai MY, Wang TH, Chen DS. Study of increased serum globulin levels in patients with chronic hepatitis C. Fifth International Symposium on Hepatitis C Virus and Related Viruses. Gold Coast, 28 August-3 September, Australia 1995: C241 (abstract).
223. Fried MW, Draguesku JO, Shindo M et al. Clinical and serological differentiation of autoimmune and hepatitis C virus related chronic hepatitis. Dig Dis Sci 1993; 38: 631-636.
224. Riezu-Boj JI, Crisostomo S, Sanchez-Ibarrola A et al. Autoantibodies: a common finding in chronic C virus (HCV) infection. J Hepatol 1991; 13 (Suppl. 2): S163.
225. Meyer zum Buschenfelde K-H, Hopf U. Studies on the pathogenesis of experimental chronic hepatitis in rabbits: induction of the disease and protective effect of allogenic liver specific protein. Br J Pathol 1974; 55: 498-508.
226. Manns MP, Griffin KJ, Sullivan KF, Johnson EF. LKM-1 autoantibodies recognize a short linear sequence in p450IID6, a cytochrome p-450 monoxygenase. J Clin Invest 1991; 88: 1370-1378.
227. Abuaf N, Lunel F, Gival PH et al. Non-organ specific autoantibodies associated to chronic C virus hepatitis. J Hepatol 1993; 18: 359-364.
228. Bellary S, Schiano T, Hartman G, Black M. Chronic hepatitis with combined features of autoimmune chronic hepatitis and chronic hepatitis C: favorable response to prednisone and azathioprine. Ann Intern Med 1995; 123: 32-34.
229. Fong TL, Valinluck B, Govindarajan S, Charboneau F, Adkins RH, Redeker AG. Short-term prednisone therapy affects aminotransferase activity and hepatitis C virus RNA level in chronic hepatitis C. Gastroenterology 1994; 107: 196-199.
230. Magrin S, Craxi A, Fabriano C et al. Hepatitis C viremia in chronic liver disease: relationship to interferon-alfa or corticosteroid treatment. Hepatology 1994; 19: 273-279.
231. Papo T, Macellin P, Bernuau J, Durand F, Poynard T, Benhamou JP. Autoimmune chronic hepatitis exacerbated by alpha-interferon. Ann Intern Med 1992; 116: 51-53.
232. Black M, Peters M. Alpha-interferon treatment of chronic hepatitis C: need for accurate diagnosis in selecting patients. Ann Intern Med 1992; 116: 86-88 (editorial).
233. Shindo M, Di Bisceglie AM, Hoffnagle JH. Acute exacerbation of liver disease during interferon alfa therapy for chronic hepatitis C. Gastroenterology 1992; 102: 1406-1408.
234. Van Thiel DH, Molloy PJ, Fiedlander L et al. Interferon α treatment of chronic hepatitis C in patients with evidence for co-existent autoimmune dysregulation. Hepato Gastroenterol 1995; 42: 900-906.
235. Calleja J-L, Albillos A, Cacho G, Iborra J, Abreu L, Escartin P. Interferon and prednisone therapy in chronic hepatitis C with non-organ-specific antibodies. J Hepatol 1996; 24: 308-312.
236. Todros L, Saracco G, Durazzo M et al. Efficacy and safety of interferon alfa therapy in chronic hepatitis C with autoantibodies to liver-kidney microsomes. Hepatology 1995; 22: 1374-1378.
237. Cayzer C, McIvor C, Crawford DHG, Cooksley WGE. Immune mediated complications of interferon therapy in chronic hepatitis. Fifth International Symposium on Hepatitis C Virus and Related Viruses. Gold Coast, 28 August-3 September, Australia 1995: C211 (abstract).
238. Schapiro GD, Friedman LS. Autoimmune hepatitis and/or hepatitis C: how to decide. Hepatology 1996; 23: 647-649.
239. Strassburg CP, Obermayer-Straub P, Manns MP. Autoimmunity in hepatitis C and D virus infection. J Viral Hep 1996; 3: 49-59.
240. Matsumori A, Matoba Y, Niskio R et al. Detection of hepatitis C virus RNA from the heart of patients with hypertrophic cardiomyopathy. Biochem Biophys Res Commun 1996; 222: 678-682.